Literature DB >> 1010852

Release of fatty acids from phosphatidylcholine by lecithin-cholesterol acyltransferase.

U Piran, T Nishida.   

Abstract

Partially purified lecithin-cholesterol acyltransferase [EC 2.3.1.43] from human plasma released fatty acids from phosphatidylcholine. Heating, sulfhydryl reagents, Ca2+, EDTA, and sodium deoxycholate had similar effects on the lecithin-cholesterol acyltransferase and fatty acid releasing activities of the preparation. A specific cofactor protein for lecithin-cholesterol acyltransferase, apoA-1, also enhanced both activities. Release of fatty acid was due to enzymatic hydrolysis of the ester linkage at carbon-2 of phosphatidylcholine. It is suggested that the two activities are due to a single enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1010852     DOI: 10.1093/oxfordjournals.jbchem.a131352

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.

Authors:  Kewei Wang; Papasani V Subbaiah
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  A high cholesterol/cholate diet induced fatty liver in spontaneously hypertensive rats.

Authors:  K Ueno; H Okuyama
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

3.  Utilization of various sterols by lecithin-cholesterol acyltransferase as acyl acceptors.

Authors:  U Piran; T Nishida
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

4.  A 31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma.

Authors:  M H Nouri-Sorkhabi; D R Sullivan; D C Roberts; P W Kuchel
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

5.  Lecithin-cholesterol acyltransferase: inhibition by local anesthetics in plasma from man and experimental animals in vitro.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

6.  Inhibition of LCAT in plasma from man and experimental animals by chlorpromazine.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1981-11       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.